Blogs
Blogs
April 17, 2023
Size Still Matters: Minimizing Complications in REBOA
It’s been just over 2 years since we published our first COBRA-OS® study, “Size Matters; first-in-human study of a novel 4 French REBOA device.” Since that study, I have personally been using the device clinically and have been hearing stories about the COBRA-OS® from customers all over North America and beyond. I have been overwhelmed by the usefulness of this tool and
July 29, 2021
REBOA around the World: Complications, Training, Technology
Dr. Adam Power, our co-founder and CMO discussed REBOA complications, training and technology at the 5th World Coalition for Trauma Care Virtual Conference.
July 29, 2021
FDA Clears the Smallest Life-Saving Bleeding Control Device, COBRA-OS®, by Front Line Medical Technologies
After three years of research and development, Front Line Medical Technologies introduces the world’s smallest REBOA device to control bleeding and help patients survive emergencies. LONDON, Ontario, June 29, 2021 (GLOBE NEWSWIRE) — Front Line Medical Technologies, Inc. announced today that the U.S. Food and Drug Administration (FDA) has cleared its COBRA-OS® (Control of Bleeding, Resuscitation, Arterial Occlusion System). The
July 29, 2021
Front Line Medical Technologies Inc. | COBRA-OS® Educational Video
The COBRA-OS® is an innovative aortic occlusion device with an extremely low profile (4 Fr) and offers an easy-to-use tool for temporary hemorrhage control and resuscitation. See the process of occlusion in detail. Smaller Size. Without Compromise.™
February 16, 2021
Front Line Medical Technologies Receives Health Canada Approval for Groundbreaking Medical Device to Control Bleeding and Help Patients Survive Emergency Situations
COBRA-OS® is the world’s smallest REBOA device, allowing frontline personnel to save more lives by controlling patients’ bleeding in fewer steps with the potential to decrease complications. LONDON, Ontario, Feb. 16, 2021 (GLOBE NEWSWIRE) — Front Line Medical Technologies, Inc. has received Health Canada approval for its COBRA-OS® (Control of Bleeding, Resuscitation, Arterial Occlusion System) device after three years of
Events
View our upcoming events
No event found!
